. . . . . . . . . . . . . . . . . . "TextLocation" . "Results" . "a(SCHEM:\"PD 98,059\") -| (p(RGD:Igf1) -> bp(GO:\"skeletal muscle hypertrophy\"))" . "p(RGD:Igf1) -> bp(GO:\"skeletal muscle hypertrophy\")" . "Approximately 2000 hand curated statements drawn from 57 PubMeds." . "Copyright (c) 2011-2012, Selventa. All Rights Reserved." . "BEL Framework Small Corpus Document" . "Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License" . . "1.6" . "Muscle hypertrophy. Local infusion of IGF-I for 14 days resulted in a 19% increase\nin muscle wet weight and an 18% increase in the total protein content of the IGF\nbut not the IGF+PD plantaris muscles (Fig. 1A, Table 1). Total protein concentration\nwas unchanged in both treatment groups (Table 1). IGF-I infusion resulted\nin a 23% increase in myofibrillar protein content (IGF group) that was completely\nblunted by coinfusion of MEK inhibitor PD-098059 (Fig. 1B)." . . "support@belframework.org" . "Selventa" . . . . "2014-07-03T14:29:34.199+02:00"^^ . . .